Furthermore, MITF−/low melanoma cells strongly expressed the Nerve Growth Factor Receptor (NGFR/CD271) identified as a marker of MICs [64] and, partially, the epithelial-to-mesenchymal transition (EMT) marker ZEB1 (Fig. 5). The gene discussed is MITF; the disease is melanoma.